Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-100977
Filing Date
2025-04-29
Accepted
2025-04-28 18:46:17
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d90024d10ka.htm   iXBRL 10-K/A 344190
2 EX-31.3 d90024dex313.htm EX-31.3 3169
3 EX-31.4 d90024dex314.htm EX-31.4 3349
  Complete submission text file 0001193125-25-100977.txt   722656

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nerv-20241231.xsd EX-101.SCH 5538
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20241231_def.xml EX-101.DEF 18249
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20241231_lab.xml EX-101.LAB 24217
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20241231_pre.xml EX-101.PRE 19529
20 EXTRACTED XBRL INSTANCE DOCUMENT d90024d10ka_htm.xml XML 10623
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36517 | Film No.: 25882101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)